• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于抗癌药物递送治疗的天然高分子纳米生物复合材料:最新进展

Natural Polymeric Nanobiocomposites for Anti-Cancer Drug Delivery Therapeutics: A Recent Update.

作者信息

Mondal Arijit, Nayak Amit Kumar, Chakraborty Prithviraj, Banerjee Sabyasachi, Nandy Bankim Chandra

机构信息

Department of Pharmaceutical Chemistry, M.R. College of Pharmaceutical Sciences and Research, Balisha 743 234, India.

Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar 751 003, India.

出版信息

Pharmaceutics. 2023 Jul 31;15(8):2064. doi: 10.3390/pharmaceutics15082064.

DOI:10.3390/pharmaceutics15082064
PMID:37631276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10459560/
Abstract

Cancer is one of the most common lethal diseases and the leading cause of mortality worldwide. Effective cancer treatment is a global problem, and subsequent advancements in nanomedicine are useful as substitute management for anti-cancer agents. Nanotechnology, which is gaining popularity, enables fast-expanding delivery methods in science for curing diseases in a site-specific approach, utilizing natural bioactive substances because several studies have established that natural plant-based bioactive compounds can improve the effectiveness of chemotherapy. Bioactive, in combination with nanotechnology, is an exceptionally alluring and recent development in the fight against cancer. Along with their nutritional advantages, natural bioactive chemicals may be used as chemotherapeutic medications to manage cancer. Alginate, starch, xanthan gum, pectin, guar gum, hyaluronic acid, gelatin, albumin, collagen, cellulose, chitosan, and other biopolymers have been employed successfully in the delivery of medicinal products to particular sites. Due to their biodegradability, natural polymeric nanobiocomposites have garnered much interest in developing novel anti-cancer drug delivery methods. There are several techniques to create biopolymer-based nanoparticle systems. However, these systems must be created in an affordable and environmentally sustainable way to be more readily available, selective, and less hazardous to increase treatment effectiveness. Thus, an extensive comprehension of the various facets and recent developments in natural polymeric nanobiocomposites utilized to deliver anti-cancer drugs is imperative. The present article provides an overview of the latest research and developments in natural polymeric nanobiocomposites, particularly emphasizing their applications in the controlled and targeted delivery of anti-cancer drugs.

摘要

癌症是最常见的致命疾病之一,也是全球主要的死亡原因。有效的癌症治疗是一个全球性问题,而纳米医学的后续进展可用作抗癌药物的替代管理方法。日益流行的纳米技术能够以位点特异性方法在科学领域实现快速扩展的给药方式,利用天然生物活性物质,因为多项研究已证实,天然植物来源的生物活性化合物可提高化疗效果。生物活性与纳米技术相结合,是抗癌斗争中一项格外诱人的最新进展。除了其营养优势外,天然生物活性化学物质可用作化疗药物来治疗癌症。藻酸盐、淀粉、黄原胶、果胶、瓜尔胶、透明质酸、明胶、白蛋白、胶原蛋白、纤维素、壳聚糖和其他生物聚合物已成功用于将药物输送到特定部位。由于其可生物降解性,天然聚合物纳米生物复合材料在开发新型抗癌药物递送方法方面引起了广泛关注。有几种技术可用于创建基于生物聚合物的纳米颗粒系统。然而,这些系统必须以经济且环境可持续的方式创建,以便更易于获得、更具选择性且危害更小,从而提高治疗效果。因此,深入了解用于递送抗癌药物的天然聚合物纳米生物复合材料的各个方面和最新进展至关重要。本文概述了天然聚合物纳米生物复合材料的最新研究和进展,特别强调了它们在抗癌药物的控释和靶向递送中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/0dd2b3c8da9a/pharmaceutics-15-02064-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/fc3595fc5d72/pharmaceutics-15-02064-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/7f9c62ec724b/pharmaceutics-15-02064-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/c67af7ab19c3/pharmaceutics-15-02064-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/effb147c5313/pharmaceutics-15-02064-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/a2cc91e6959a/pharmaceutics-15-02064-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/f70848282274/pharmaceutics-15-02064-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/70eb80f5fb47/pharmaceutics-15-02064-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/49921738e390/pharmaceutics-15-02064-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/9669863fe1aa/pharmaceutics-15-02064-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/1034caa0c10f/pharmaceutics-15-02064-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/aacbe2c45f5c/pharmaceutics-15-02064-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/759645e1f046/pharmaceutics-15-02064-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/8a727357af7a/pharmaceutics-15-02064-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/2efff0527986/pharmaceutics-15-02064-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/1e37bcacc514/pharmaceutics-15-02064-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/2dad06bf6a19/pharmaceutics-15-02064-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/0dd2b3c8da9a/pharmaceutics-15-02064-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/fc3595fc5d72/pharmaceutics-15-02064-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/7f9c62ec724b/pharmaceutics-15-02064-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/c67af7ab19c3/pharmaceutics-15-02064-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/effb147c5313/pharmaceutics-15-02064-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/a2cc91e6959a/pharmaceutics-15-02064-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/f70848282274/pharmaceutics-15-02064-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/70eb80f5fb47/pharmaceutics-15-02064-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/49921738e390/pharmaceutics-15-02064-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/9669863fe1aa/pharmaceutics-15-02064-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/1034caa0c10f/pharmaceutics-15-02064-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/aacbe2c45f5c/pharmaceutics-15-02064-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/759645e1f046/pharmaceutics-15-02064-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/8a727357af7a/pharmaceutics-15-02064-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/2efff0527986/pharmaceutics-15-02064-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/1e37bcacc514/pharmaceutics-15-02064-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/2dad06bf6a19/pharmaceutics-15-02064-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aef/10459560/0dd2b3c8da9a/pharmaceutics-15-02064-g017.jpg

相似文献

1
Natural Polymeric Nanobiocomposites for Anti-Cancer Drug Delivery Therapeutics: A Recent Update.用于抗癌药物递送治疗的天然高分子纳米生物复合材料:最新进展
Pharmaceutics. 2023 Jul 31;15(8):2064. doi: 10.3390/pharmaceutics15082064.
2
Biopolymeric nanoparticles based effective delivery of bioactive compounds toward the sustainable development of anticancerous therapeutics.基于生物聚合物纳米颗粒的生物活性化合物有效递送促进抗癌治疗的可持续发展。
Front Nutr. 2022 Jul 15;9:963413. doi: 10.3389/fnut.2022.963413. eCollection 2022.
3
Lignin, lipid, protein, hyaluronic acid, starch, cellulose, gum, pectin, alginate and chitosan-based nanomaterials for cancer nanotherapy: Challenges and opportunities.基于木质素、脂质、蛋白质、透明质酸、淀粉、纤维素、胶、果胶、藻酸盐和壳聚糖的癌症纳米治疗用纳米材料:挑战与机遇。
Int J Biol Macromol. 2021 May 1;178:193-228. doi: 10.1016/j.ijbiomac.2021.02.123. Epub 2021 Feb 22.
4
The Use of Chitosan, Alginate, and Pectin in the Biomedical and Food Sector-Biocompatibility, Bioadhesiveness, and Biodegradability.壳聚糖、藻酸盐和果胶在生物医学与食品领域的应用——生物相容性、生物黏附性和生物降解性
Polymers (Basel). 2019 Nov 8;11(11):1837. doi: 10.3390/polym11111837.
5
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.癌症的先进靶向疗法:药物纳米载体,化疗的未来。
Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23.
6
Biopolymer-Based Nanomedicine for Cancer Therapy: Opportunities and Challenges.基于生物聚合物的癌症治疗纳米医学:机遇与挑战。
Int J Nanomedicine. 2024 Jul 22;19:7415-7471. doi: 10.2147/IJN.S460047. eCollection 2024.
7
Progresses in chitin, chitosan, starch, cellulose, pectin, alginate, gelatin and gum based (nano)catalysts for the Heck coupling reactions: A review.基于几丁质、壳聚糖、淀粉、纤维素、果胶、藻酸盐、明胶和树胶的(纳米)催化剂在Heck偶联反应中的研究进展:综述
Int J Biol Macromol. 2021 Dec 1;192:771-819. doi: 10.1016/j.ijbiomac.2021.09.162. Epub 2021 Oct 8.
8
Natural polysaccharide-based biodegradable polymeric platforms for transdermal drug delivery system: a critical analysis.基于天然多糖的可生物降解聚合物平台用于透皮给药系统:批判性分析。
Drug Deliv Transl Res. 2022 Nov;12(11):2649-2666. doi: 10.1007/s13346-022-01152-3. Epub 2022 Apr 30.
9
Recent development of chitosan-based polyelectrolyte complexes with natural polysaccharides for drug delivery.壳聚糖基聚电解质复合物与天然多糖在药物传递中的最新进展。
Int J Biol Macromol. 2014 Mar;64:353-67. doi: 10.1016/j.ijbiomac.2013.12.017. Epub 2013 Dec 17.
10
Polysaccharide-Drug Conjugates: A Tool for Enhanced Cancer Therapy.多糖-药物缀合物:一种增强癌症治疗效果的工具。
Polymers (Basel). 2022 Feb 27;14(5):950. doi: 10.3390/polym14050950.

引用本文的文献

1
Bioengineered and biodegradable 3D scaffold for controlled drug delivery of 5-fluorouracil-loaded nanoparticle for bone tumor treatment.用于负载5-氟尿嘧啶纳米颗粒的可控药物递送以治疗骨肿瘤的生物工程可生物降解三维支架
Med Oncol. 2025 Jul 30;42(9):395. doi: 10.1007/s12032-025-02891-2.
2
Metformin and its Nanoformulations in Cancer Prevention and Therapy.二甲双胍及其纳米制剂在癌症预防与治疗中的应用
Curr Pharm Des. 2025 Apr 8. doi: 10.2174/0113816128367242250214052019.
3
Formulation Development of Natural Polymeric Nanoparticles, In Vitro Antiaging Evaluation, and Metabolite Profiling of Leaf Extracts.

本文引用的文献

1
Facile synthesis of copolymerized cellulose grafted hydrogel doped calcium oxide nanocomposites with improved antioxidant activity for anti-arthritic and controlled release of doxorubicin for anti-cancer evaluation.简便合成具有改善抗氧化活性的共聚纤维素接枝水凝胶掺杂氧化钙纳米复合材料用于抗关节炎及阿霉素控释以进行抗癌评估
Int J Biol Macromol. 2023 Apr 30;235:123874. doi: 10.1016/j.ijbiomac.2023.123874. Epub 2023 Mar 2.
2
Natural Biopolymers as Smart Coating Materials of Mesoporous Silica Nanoparticles for Drug Delivery.天然生物聚合物作为介孔二氧化硅纳米粒子用于药物递送的智能涂层材料
Pharmaceutics. 2023 Jan 29;15(2):447. doi: 10.3390/pharmaceutics15020447.
3
天然聚合物纳米颗粒的制剂开发、体外抗老化评估及叶提取物的代谢物谱分析
Pharmaceuticals (Basel). 2025 Feb 20;18(3):288. doi: 10.3390/ph18030288.
4
Cancer theragnostics: closing the loop for advanced personalized cancer treatment through the platform integration of therapeutics and diagnostics.癌症治疗诊断学:通过治疗与诊断的平台整合,为先进的个性化癌症治疗闭环。
Front Bioeng Biotechnol. 2025 Jan 17;12:1499474. doi: 10.3389/fbioe.2024.1499474. eCollection 2024.
5
Iron oxide nanoparticles: a versatile nanoplatform for the treatment and diagnosis of ovarian cancer.氧化铁纳米颗粒:用于卵巢癌治疗与诊断的多功能纳米平台。
Ther Deliv. 2025 Apr;16(4):379-392. doi: 10.1080/20415990.2024.2442301. Epub 2024 Dec 26.
6
Radiation-induced nanogel engineering based on pectin for pH-responsive rutin delivery for cancer treatment.基于果胶的辐射诱导纳米凝胶工程用于癌症治疗中pH响应性芦丁递送
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):5249-5271. doi: 10.1007/s00210-024-03573-y. Epub 2024 Nov 14.
7
A cutting-edge new framework for the pain management in children: nanotechnology.一种用于儿童疼痛管理的前沿新框架:纳米技术。
Front Mol Neurosci. 2024 Sep 10;17:1391092. doi: 10.3389/fnmol.2024.1391092. eCollection 2024.
8
Smart delivery vehicles for cancer: categories, unique roles and therapeutic strategies.用于癌症治疗的智能运载工具:类别、独特作用及治疗策略
Nanoscale Adv. 2024 Jun 20;6(17):4275-4308. doi: 10.1039/d4na00285g. eCollection 2024 Aug 20.
9
Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System.基于纳米递药系统提高仑伐替尼抗肿瘤效率的策略及研究进展。
Int J Nanomedicine. 2024 Jun 10;19:5581-5603. doi: 10.2147/IJN.S460844. eCollection 2024.
10
Exploring the Potentials of Hyaluronic Acid-coated Polymeric Nanoparticles in Enhanced Cancer Treatment by Precision Drug Delivery, Tackling Drug Resistance, and Reshaping the Tumour Micro Environment.探索透明质酸包被的聚合物纳米颗粒在精准给药增强癌症治疗、克服耐药性和重塑肿瘤微环境方面的潜力。
Curr Med Chem. 2024 Apr 3. doi: 10.2174/0109298673302510240328050115.
Recent Progress of Gold-Based Nanostructures towards Future Emblem of Photo-Triggered Cancer Theranostics: A Special Focus on Combinatorial Phototherapies.
基于金的纳米结构在光触发癌症诊疗未来标志方面的最新进展:特别关注联合光疗法。
Pharmaceutics. 2023 Jan 28;15(2):433. doi: 10.3390/pharmaceutics15020433.
4
Polymer Gels: Classification and Recent Developments in Biomedical Applications.聚合物凝胶:生物医学应用中的分类与最新进展
Gels. 2023 Feb 17;9(2):161. doi: 10.3390/gels9020161.
5
Collagen-Based Biomaterials for Tissue Engineering.用于组织工程的基于胶原蛋白的生物材料。
ACS Biomater Sci Eng. 2023 Mar 13;9(3):1132-1150. doi: 10.1021/acsbiomaterials.2c00730. Epub 2023 Feb 17.
6
Novel Carboxymethyl Cellulose-Based Hydrogel with Core-Shell FeO@SiO Nanoparticles for Quercetin Delivery.用于槲皮素递送的具有核壳结构FeO@SiO纳米粒子的新型羧甲基纤维素基水凝胶
Materials (Basel). 2022 Dec 7;15(24):8711. doi: 10.3390/ma15248711.
7
Molecular Mechanisms of Action of Eugenol in Cancer: Recent Trends and Advancement.丁香酚在癌症中的作用分子机制:最新趋势与进展
Life (Basel). 2022 Nov 6;12(11):1795. doi: 10.3390/life12111795.
8
Evidence-based biomaterials research.基于证据的生物材料研究。
Bioact Mater. 2022 Apr 25;15:495-503. doi: 10.1016/j.bioactmat.2022.04.014. eCollection 2022 Sep.
9
Systematic Approach to Mimic Phenolic Natural Polymers for Biofabrication.用于生物制造的模拟酚类天然聚合物的系统方法。
Polymers (Basel). 2022 Mar 22;14(7):1282. doi: 10.3390/polym14071282.
10
Recent Trends in Assessment of Cellulose Derivatives in Designing Novel and Nanoparticulate-Based Drug Delivery Systems for Improvement of Oral Health.用于改善口腔健康的新型纳米颗粒药物递送系统设计中纤维素衍生物评估的最新趋势
Polymers (Basel). 2021 Dec 27;14(1):92. doi: 10.3390/polym14010092.